Literature DB >> 17614126

Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B.

G Ferrandina, G Scambia, F Legge, M Petrillo, V Salutari.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17614126     DOI： 10.1016/j.ygyno.2007.05.016

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  16 in total

1.  Differential routes of carboplatin administration influence lymphocyte apoptosis in retroperitoneal lymph nodes.

Authors:  Yong-Wen Huang; Zheng Zeng; Su Li; Ji-Hong Liu
Journal:  Tumour Biol       Date:  2012-07-29

Review 2.  Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?

Authors:  Luca Bertero; Federica Massa; Jasna Metovic; Roberto Zanetti; Isabella Castellano; Umberto Ricardi; Mauro Papotti; Paola Cassoni
Journal:  Virchows Arch       Date:  2017-12-05       Impact factor: 4.064

3.  Presentation and Management of Inguinal Lymphadenopathy in Ovarian Cancer.

Authors:  Shveta Giri; Swati H Shah; Kanika Batra; Vandana Jain; Himanshu Shukla; Rupinder Sekhon; Sudhir Rawal
Journal:  Indian J Surg Oncol       Date:  2016-09-21

Review 4.  Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.

Authors:  Tsukasa Saida; Yumiko Oishi Tanaka; Koji Matsumoto; Toyomi Satoh; Hiroyuki Yoshikawa; Manabu Minami
Journal:  Jpn J Radiol       Date:  2015-12-22       Impact factor: 2.374

Review 5.  Ovarian cancer.

Authors:  Ursula A Matulonis; Anil K Sood; Lesley Fallowfield; Brooke E Howitt; Jalid Sehouli; Beth Y Karlan
Journal:  Nat Rev Dis Primers       Date:  2016-08-25       Impact factor: 52.329

6.  What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.

Authors:  Bunja J Rungruang; Austin Miller; Thomas C Krivak; Neil S Horowitz; Noah Rodriguez; Chad A Hamilton; Floor J Backes; Linda F Carson; Michael Friedlander; David G Mutch; Michael J Goodheart; Krishnansu S Tewari; Robert M Wenham; Michael A Bookman; G Larry Maxwell; Scott D Richard
Journal:  Cancer       Date:  2016-11-16       Impact factor: 6.860

7.  Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal Cancers.

Authors:  Ayumu Matsuoka; Shinichi Tate; Kyoko Nishikimi; Masami Iwamoto; Satoyo Otsuka; Makio Shozu
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

8.  Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer.

Authors:  Su-Jin Baek; Jeong-Yeol Park; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  J Gynecol Oncol       Date:  2008-12-29       Impact factor: 4.401

9.  [New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer].

Authors:  A K Höhn; J Einenkel; C Wittekind; L-C Horn
Journal:  Pathologe       Date:  2014-07       Impact factor: 1.011

10.  Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.

Authors:  Francesco Legge; Marco Petrillo; Vincenzo Adamo; Salvatore Pisconti; Giovanni Scambia; Gabriella Ferrandina
Journal:  BMC Cancer       Date:  2008-12-12       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.